Fresenius Other Operating Expenses vs Income Before Tax Analysis

FMS Stock

USD 20.10 0.11 0.54%

Fresenius Medical financial indicator trend analysis is much more than just examining Fresenius Medical Care latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Fresenius Medical Care is a good investment. Please check the relationship between Fresenius Medical Other Operating Expenses and its Income Before Tax accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Other Operating Expenses vs Income Before Tax

Other Operating Expenses vs Income Before Tax Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Fresenius Medical Care Other Operating Expenses account and Income Before Tax. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Fresenius Medical's Other Operating Expenses and Income Before Tax is 0.52. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of Fresenius Medical Care, assuming nothing else is changed. The correlation between historical values of Fresenius Medical's Other Operating Expenses and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Fresenius Medical Care are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Other Operating Expenses i.e., Fresenius Medical's Other Operating Expenses and Income Before Tax go up and down completely randomly.

Correlation Coefficient

0.52

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Fresenius Medical Care. It is also known as Fresenius Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Fresenius Medical income statement and is an important metric when analyzing Fresenius Medical Care profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most indicators from Fresenius Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Fresenius Medical Care current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

At this time, Fresenius Medical's Tax Provision is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 6.94 in 2024, whereas Selling General Administrative is likely to drop slightly above 3 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	5.1B	5.3B	4.9B	3.7B
Total Revenue	17.6B	19.4B	19.5B	11.4B

Gross Profit Total Revenue

Fresenius Medical fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Common Stock Shares Outstanding		-0.56	-0.65	-0.67	-0.54	-0.49	-0.58	-0.66	-0.55	-0.36	-0.37	-0.61	-0.62	-0.41	-0.18	0.18	-0.59	-0.68	0.01	-0.59	-0.6	-0.55	-0.36	-0.5	0.0	-0.17
Total Assets	-0.56		0.97	0.67	0.94	0.98	0.62	0.94	0.87	0.96	0.67	1.0	0.62	0.73	0.9	0.56	0.94	0.82	-0.25	0.85	0.99	0.4	0.96	0.77	-0.34	0.43
Short Long Term Debt Total	-0.65	0.97		0.63	0.89	0.91	0.63	0.99	0.81	0.89	0.55	0.98	0.66	0.61	0.82	0.45	0.97	0.78	-0.17	0.83	0.99	0.38	0.87	0.75	-0.26	0.35
Other Current Liab	-0.67	0.67	0.63		0.76	0.69	0.72	0.58	0.81	0.58	0.82	0.67	0.48	0.81	0.45	0.16	0.52	0.88	0.1	0.81	0.64	0.69	0.63	0.72	0.04	0.06
Total Current Liabilities	-0.54	0.94	0.89	0.76		0.96	0.63	0.84	0.84	0.9	0.77	0.94	0.58	0.8	0.83	0.45	0.8	0.79	-0.14	0.92	0.92	0.36	0.92	0.92	-0.21	0.31
Total Stockholder Equity	-0.49	0.98	0.91	0.69	0.96		0.59	0.86	0.86	0.97	0.75	0.97	0.58	0.8	0.91	0.56	0.88	0.81	-0.29	0.87	0.95	0.35	0.97	0.8	-0.37	0.45
Property Plant And Equipment Net	-0.58	0.62	0.63	0.72	0.63	0.59		0.62	0.8	0.57	0.61	0.63	0.06	0.66	0.52	0.43	0.57	0.79	-0.19	0.59	0.62	0.86	0.57	0.61	-0.2	0.33
Net Debt	-0.66	0.94	0.99	0.58	0.84	0.86	0.62		0.77	0.85	0.45	0.96	0.66	0.53	0.78	0.44	0.97	0.75	-0.14	0.79	0.97	0.37	0.82	0.69	-0.23	0.33
Retained Earnings	-0.55	0.87	0.81	0.81	0.84	0.86	0.8	0.77		0.86	0.81	0.86	0.49	0.88	0.8	0.6	0.79	0.97	-0.29	0.77	0.85	0.68	0.85	0.66	-0.35	0.46
Accounts Payable	-0.36	0.96	0.89	0.58	0.9	0.97	0.57	0.85	0.86		0.67	0.94	0.5	0.74	0.97	0.71	0.89	0.78	-0.34	0.79	0.94	0.35	0.98	0.7	-0.44	0.51
Cash	-0.37	0.67	0.55	0.82	0.77	0.75	0.61	0.45	0.81	0.67		0.64	0.35	0.99	0.59	0.33	0.45	0.78	-0.25	0.71	0.6	0.52	0.74	0.7	-0.31	0.35
Non Current Assets Total	-0.61	1.0	0.98	0.67	0.94	0.97	0.63	0.96	0.86	0.94	0.64		0.65	0.71	0.87	0.51	0.95	0.82	-0.24	0.86	1.0	0.4	0.93	0.77	-0.32	0.42
Non Currrent Assets Other	-0.62	0.62	0.66	0.48	0.58	0.58	0.06	0.66	0.49	0.5	0.35	0.65		0.39	0.36	-0.07	0.64	0.55	0.04	0.65	0.65	-0.03	0.48	0.45	-0.06	0.11
Cash And Short Term Investments	-0.41	0.73	0.61	0.81	0.8	0.8	0.66	0.53	0.88	0.74	0.99	0.71	0.39		0.67	0.43	0.54	0.84	-0.3	0.73	0.67	0.55	0.79	0.7	-0.35	0.41
Net Receivables	-0.18	0.9	0.82	0.45	0.83	0.91	0.52	0.78	0.8	0.97	0.59	0.87	0.36	0.67		0.83	0.84	0.67	-0.37	0.68	0.88	0.28	0.95	0.62	-0.46	0.51
Common Stock Total Equity	0.18	0.56	0.45	0.16	0.45	0.56	0.43	0.44	0.6	0.71	0.33	0.51	-0.07	0.43	0.83		0.55	0.45	-0.3	0.25	0.54	0.32	0.69	0.23	-0.35	0.4
Non Current Liabilities Total	-0.59	0.94	0.97	0.52	0.8	0.88	0.57	0.97	0.79	0.89	0.45	0.95	0.64	0.54	0.84	0.55		0.76	-0.26	0.72	0.97	0.38	0.86	0.58	-0.35	0.45
Inventory	-0.68	0.82	0.78	0.88	0.79	0.81	0.79	0.75	0.97	0.78	0.78	0.82	0.55	0.84	0.67	0.45	0.76		-0.2	0.78	0.81	0.72	0.78	0.62	-0.25	0.38
Other Current Assets	0.01	-0.25	-0.17	0.1	-0.14	-0.29	-0.19	-0.14	-0.29	-0.34	-0.25	-0.24	0.04	-0.3	-0.37	-0.3	-0.26	-0.2		-0.03	-0.23	-0.09	-0.27	0.01	0.95	-0.96
Other Stockholder Equity	-0.59	0.85	0.83	0.81	0.92	0.87	0.59	0.79	0.77	0.79	0.71	0.86	0.65	0.73	0.68	0.25	0.72	0.78	-0.03		0.83	0.31	0.77	0.89	-0.12	0.19
Total Liab	-0.6	0.99	0.99	0.64	0.92	0.95	0.62	0.97	0.85	0.94	0.6	1.0	0.65	0.67	0.88	0.54	0.97	0.81	-0.23	0.83		0.39	0.93	0.74	-0.32	0.42
Property Plant And Equipment Gross	-0.55	0.4	0.38	0.69	0.36	0.35	0.86	0.37	0.68	0.35	0.52	0.4	-0.03	0.55	0.28	0.32	0.38	0.72	-0.09	0.31	0.39		0.38	0.26	-0.11	0.24
Total Current Assets	-0.36	0.96	0.87	0.63	0.92	0.97	0.57	0.82	0.85	0.98	0.74	0.93	0.48	0.79	0.95	0.69	0.86	0.78	-0.27	0.77	0.93	0.38		0.72	-0.36	0.43
Short Term Debt	-0.5	0.77	0.75	0.72	0.92	0.8	0.61	0.69	0.66	0.7	0.7	0.77	0.45	0.7	0.62	0.23	0.58	0.62	0.01	0.89	0.74	0.26	0.72		-0.02	0.1
Intangible Assets	0.0	-0.34	-0.26	0.04	-0.21	-0.37	-0.2	-0.23	-0.35	-0.44	-0.31	-0.32	-0.06	-0.35	-0.46	-0.35	-0.35	-0.25	0.95	-0.12	-0.32	-0.11	-0.36	-0.02		-0.96
Common Stock	-0.17	0.43	0.35	0.06	0.31	0.45	0.33	0.33	0.46	0.51	0.35	0.42	0.11	0.41	0.51	0.4	0.45	0.38	-0.96	0.19	0.42	0.24	0.43	0.1	-0.96

Click cells to compare fundamentals

Fresenius Medical Account Relationship Matchups

Fresenius Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	302.7M	294.3M	293.1M	293.2M	293.4M	405.8M
Total Assets	32.9B	31.7B	34.4B	35.8B	33.9B	18.7B
Short Long Term Debt Total	13.8B	12.4B	13.3B	13.2B	12.1B	6.2B
Other Current Liab	2.7B	3.0B	3.3B	3.4B	3.6B	3.8B
Total Current Liabilities	7.0B	6.2B	7.3B	6.5B	6.1B	3.6B
Total Stockholder Equity	13.2B	12.3B	14.0B	15.4B	13.6B	7.8B
Property Plant And Equipment Net	8.5B	4.1B	4.3B	4.2B	7.5B	7.8B
Net Debt	12.8B	11.3B	11.8B	11.9B	10.6B	5.7B
Retained Earnings	9.5B	10.3B	10.8B	10.7B	10.9B	11.5B
Accounts Payable	835.2M	827.4M	857.5M	931.3M	885.1M	550.9M
Cash	1.0B	1.1B	1.5B	1.3B	1.4B	1.5B
Non Current Assets Total	25.8B	24.4B	26.4B	27.6B	25.2B	13.8B
Non Currrent Assets Other	752.5M	4.8B	5.2B	5.0B	223.6M	212.4M
Cash And Short Term Investments	1.1B	1.2B	1.6B	1.4B	1.5B	1.6B
Net Receivables	4.0B	3.6B	3.9B	4.0B	4.1B	2.6B
Common Stock Total Equity	308.1M	307.9M	304.4M	292.9M	336.8M	304.7M
Liabilities And Stockholders Equity	32.9B	31.7B	34.4B	35.8B	33.9B	18.7B
Non Current Liabilities Total	12.7B	13.2B	13.1B	13.8B	13.0B	7.2B
Inventory	1.7B	1.9B	2.0B	2.3B	2.2B	2.3B
Other Current Assets	320.7M	455.7M	342.9M	351.1M	332.6M	348.1M
Other Stockholder Equity	4.5B	4.0B	4.2B	4.8B	3.4B	3.2B
Total Liab	19.7B	19.4B	20.4B	20.3B	19.1B	10.8B
Property Plant And Equipment Gross	8.5B	8.2B	4.3B	4.2B	17.9B	17.0B
Total Current Assets	7.2B	7.3B	8.0B	8.2B	8.7B	4.9B
Accumulated Other Comprehensive Income	(1.0B)	(2.2B)	(1.3B)	(388.5M)	(975.2M)	(926.4M)
Short Term Debt	3.3B	1.7B	2.6B	2.0B	1.6B	1.1B
Intangible Assets	1.4B	1.4B	1.5B	1.5B	1.4B	1.7B
Common Stock	304.4M	292.9M	293.0M	293.4M	337.4M	281.4M
Current Deferred Revenue	201.0M	606.3M	518.0M	105.7M	85.8M	81.5M
Other Liab	2.1B	2.5B	2.4B	2.7B	3.1B	3.2B
Other Assets	1.1B	1.1B	1.2B	1.1B	1.3B	1.4B
Long Term Debt	6.5B	6.8B	6.6B	7.2B	7.0B	5.7B
Property Plant Equipment	8.5B	8.2B	8.6B	8.3B	9.6B	10.1B
Good Will	14.0B	13.0B	14.4B	15.8B	14.7B	13.9B
Net Tangible Assets	(3.5B)	(3.1B)	(3.1B)	(3.3B)	(3.8B)	(4.0B)
Short Term Investments	133.3M	161.7M	136.4M	170.0M	136.3M	152.7M
Long Term Investments	696.9M	761.1M	786.9M	773.7M	1.3B	853.1M
Short Long Term Debt	2.6B	1.1B	1.9B	1.4B	944.6M	1.7B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Stock, refer to the following important reports:

How To Invest In Fresenius

Details

Is Fresenius Stock a good investment?

Details

What is Fresenius Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Fresenius Stock analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.

	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio

Is Fresenius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fresenius Medical. If investors know Fresenius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.353

Dividend Share

1.19

Earnings Share

0.91

Revenue Per Share

33.1505

Quarterly Revenue Growth

(0)

The market value of Fresenius Medical Care is measured differently than its book value, which is the value of Fresenius that is recorded on the company's balance sheet. Investors also form their own opinion of Fresenius Medical's value that differs from its market value or its book value, called intrinsic value, which is Fresenius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fresenius Medical's market value can be influenced by many factors that don't directly affect Fresenius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Fresenius Other Operating Expenses vs Income Before Tax Analysis

Other Operating Expenses vs Income Before Tax

Other Operating Expenses vs Income Before Tax Correlation Analysis

Correlation Coefficient

Other Operating Expenses

Income Before Tax

Fresenius Medical fundamental ratios Correlations

Fresenius Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Fresenius Medical fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Fresenius Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Total Liab	+ 1.0	Non Current Assets Total
Total Liab	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.99	Cash

Common Stock	- 0.96	Intangible Assets
Common Stock	- 0.96	Other Current Assets
Inventory	- 0.68	Common Stock Shares Outstanding
Other Current Liab	- 0.67	Common Stock Shares Outstanding
Net Debt	- 0.66	Common Stock Shares Outstanding
Short Long Term Debt Total	- 0.65	Common Stock Shares Outstanding